Summary

Handheld Ultrasound Devices Market Growth &Trends

The global handheld ultrasound devices market size is anticipated to reach USD 442.7 million by 2030, registering a CAGR of 5.71% from 2023 to 2030, according to a new report by Grand View Research, Inc. An increase in patient preference for minimally invasive procedures, rise in the utilization of imaging devices in medical emergencies, also rapid advancements in healthcare technology are key contributors to the market growth. The growing focus on point-of-care ultrasonography and the instantaneous and speedy estimating capabilities of handheld ultrasound devices drive the market growth. The demand for real-time delivery and image-based diagnostic systems has increased, contributing to the market's expansion. Due to their compact size, these devices are ideal for physicians, nurses, and sonographers when traveling to a patient. Doctors can carry them comfortably in their pockets or folders.

In addition, wireless ultrasound devices have made image-seizing for detection and treatment convenient. Hence, using these devices helps avoid complications associated with invasive surgeries. Consequently, surgeons increasingly shift toward noninvasive techniques, such as handheld ultrasound devices. These factors are expected to propel the growth of the market. The increasing product adoption for diagnosis and treatment is boosting the market growth. Handheld ultrasounds are also used in various applications, such as bladder volume, abdominal screening, obstetrics, musculoskeletal, and ultrasound-guided treatment. For instance, as per the World Health Organization (WHO) report of July 2022, about 1.71 billion people suffer from musculoskeletal conditions worldwide. Also, therapeutic handheld ultrasound devices support minimally invasive surgery.

Handheld Ultrasound Devices Market Report Highlights

• Based on technology, the 3D/4D ultrasound segment dominated the market in 2022 with the largest share due to improved visualization, enhanced diagnostic accuracy, and technological advancement

• Based on application, the musculoskeletal segment dominated the market in 2022 with the highest share owing to the increasing geriatric population globally as there is an increasing prevalence of musculoskeletal conditions, such as fractures and osteoarthritis, in aging populations

• The hospitals segment held the largest share in 2022 as hospitals conduct more ultrasound studies, in terms of quantity and variety, than any other healthcare setting

• North America dominated the overall market with the highest revenue share in 2022 owing to the development of a sophisticated healthcare system, a rise in the incidence of infectious diseases & illnesses, and a growing focus on developing novel goods

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Technology
1.1.2. Application
1.1.3. End-user
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for Primary Interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for Primary Interviews in Latin America
1.3.5.5. Data for Primary Interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation and Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Application outlook
2.2.3. End-user outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Handheld Ultrasound Devices Market Variables, Trends and Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing adoption of handheld ultrasound devices for diagnosis and treatment
3.2.1.2. Rising demand for minimally invasive surgical procedures
3.2.1.3. Technological advancements
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of skilled professionals
3.2.2.2. Limitations of the handheld ultrasound devices
3.2.3. Market Opportunity Analysis
3.3. Handheld Ultrasound Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic Landscape
3.3.3. Covid-19 Impact Analysis
Chapter 4. Handheld Ultrasound Devices Market: Technology Estimates and Trend Analysis
4.1. Definitions and Scope
4.1.1. 2D Ultrasound
4.1.2. 3D/4D Ultrasound
4.1.3. Doppler Ultrasound
4.2. Technology Market Share, 2018 and 2030
4.3. Segment Dashboard
4.4. Global Surgical Refractor Market by Technology Outlook
4.5. Market Size and Forecasts and Trend Analyses, 2023 to 2030 for the following
4.5.1. 2D Ultrasound
4.5.1.1. 2D ultrasound market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. 3D/4D Ultrasound
4.5.2.1. 3D/4D ultrasound market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Doppler Ultrasound
4.5.3.1. Doppler ultrasound market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Handheld Ultrasound Devices Market: Application Estimates and Trend Analysis
5.1. Definitions and Scope
5.1.1. Obstetrics/Gynecology
5.1.2. Cardiovascular
5.1.3. Urology
5.1.4. Gastroenterology
5.1.5. Musculoskeletal
5.1.6. Trauma
5.1.7. Others
5.2. Application Market Share, 2018 and 2030
5.3. Segment Dashboard
5.4. Global Handheld Ultrasound Devices Market by Application Outlook
5.5. Market Size and Forecasts and Trend Analyses, 2023 to 2030 for the following
5.5.1. Obstetrics/Gynecology
5.5.1.1. Obstetrics/ gynecology market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Cardiovascular
5.5.2.1. Cardiovascular market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Urology
5.5.3.1. Urology market estimates and forecast 2018 to 2030 (USD Million)
5.5.4. Gastroenterology
5.5.4.1. Gastroenterology market estimates and forecast 2018 to 2030 (USD Million)
5.5.5. Musculoskeletal
5.5.5.1. Musculoskeletal Market Estimates and Forecast 2018 to 2030 (USD Million)
5.5.6. Trauma
5.5.6.1. Trauma market estimates and forecast 2018 to 2030 (USD Million)
5.5.7. Others
5.5.7.1. Other Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Handheld Ultrasound Devices: End-use Estimates and Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Primary Clinics
6.1.3. Others
6.2. End Use Market Share, 2018 and 2030
6.3. Segment Dashboard
6.4. Global Handheld Ultrasound Devices Market by End-use Outlook
6.5. Market Size and Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Primary Clinics
6.5.2.1. Primary clinics market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Others
6.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Handheld Ultrasound Devices Market: Regional Estimates and Trend Analysis
7.1. Regional market share analysis, 2022 and 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2022
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. Market Application, and Forecasts and Trend Analysis, 2018 to 2030
7.6. North America
7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.6.2. U.S.
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement scenario
7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
7.6.3. Canada
7.6.3.1. Key country dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement scenario
7.6.3.5. Canada market estimates and forecasts, 2018 - 2030
7.7. Europe
7.7.1. UK
7.7.1.1. Key country dynamics
7.7.1.2. Competitive Scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement scenario
7.7.1.5. UK market estimates and forecasts, 2018 - 2030
7.7.2. Germany
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Germany market estimates and forecasts, 2018 - 2030
7.7.3. France
7.7.3.1. Key country dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement scenario
7.7.3.5. France market estimates and forecasts, 2018 - 2030
7.7.4. Italy
7.7.4.1. Key country dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement scenario
7.7.4.5. Italy market estimates and forecasts, 2018 - 2030
7.7.5. Spain
7.7.5.1. Key country dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement scenario
7.7.5.5. Spain market estimates and forecasts, 2018 - 2030
7.7.6. Denmark
7.7.6.1. Key country dynamics
7.7.6.2. Competitive Scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement scenario
7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
7.7.7. Sweden
7.7.7.1. Key country dynamics
7.7.7.2. Competitive Scenario
7.7.7.3. Regulatory framework
7.7.7.4. Reimbursement scenario
7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
7.7.8. Norway
7.7.8.1. Key country dynamics
7.7.8.2. Competitive Scenario
7.7.8.3. Regulatory framework
7.7.8.4. Reimbursement scenario
7.7.8.5. Norway market estimates and forecasts, 2018 - 2030
7.8. Asia Pacific
7.8.1. Japan
7.8.1.1. Key country dynamics
7.8.1.2. Competitive Scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement scenario
7.8.1.5. Japan market estimates and forecasts, 2018 - 2030
7.8.2. India
7.8.2.1. Key country dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement scenario
7.8.2.5. India market estimates and forecasts, 2018 - 2030
7.8.3. China
7.8.3.1. Key country dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory framework
7.8.3.4. Reimbursement scenario
7.8.3.5. China market estimates and forecasts, 2018 - 2030
7.8.4. South Korea
7.8.4.1. Key country dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory framework
7.8.4.4. Reimbursement scenario
7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
7.8.5. Australia
7.8.5.1. Key country dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory framework
7.8.5.4. Reimbursement scenario
7.8.5.5. Australia market estimates and forecasts, 2018 - 2030
7.8.6. Thailand
7.8.6.1. Key country dynamics
7.8.6.2. Competitive Scenario
7.8.6.3. Regulatory framework
7.8.6.4. Reimbursement scenario
7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
7.9. Latin America
7.9.1. Brazil
7.9.1.1. Key country dynamics
7.9.1.2. Competitive Scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement scenario
7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
7.9.2. Mexico
7.9.2.1. Key country dynamics
7.9.2.2. Competitive Scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement scenario
7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
7.9.3. Argentina
7.9.3.1. Key country dynamics
7.9.3.2. Competitive Scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement scenario
7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
7.10. MEA
7.10.1. South Africa
7.10.1.1. Key country dynamics
7.10.1.2. Competitive Scenario
7.10.1.3. Regulatory framework
7.10.1.4. Reimbursement scenario
7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
7.10.2. Saudi Arabia
7.10.2.1. Key country dynamics
7.10.2.2. Competitive Scenario
7.10.2.3. Regulatory framework
7.10.2.4. Reimbursement scenario
7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
7.10.3. UAE
7.10.3.1. Key country dynamics
7.10.3.2. Competitive Scenario
7.10.3.3. Regulatory framework
7.10.3.4. Reimbursement scenario
7.10.3.5. UAE market estimates and forecasts, 2018 - 2030
7.10.4. Kuwait
7.10.4.1. Key country dynamics
7.10.4.2. Competitive Scenario
7.10.4.3. Regulatory framework
7.10.4.4. Reimbursement scenario
7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 8. Competitive Landscape
8.1. Recent Developments and Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key Company Market Share Analysis, 2022
8.3.4. GE HealthCare
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Koninklijke Philips N.V.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. BenQ Medical Technology
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. CHISON Medical Technologies Co., Ltd.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Dawei Medical (Jiangsu) Corp., Ltd.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Viatom Technology Co., Ltd.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. TELEMED MEDICAL SYSTEMS S.r.l.
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Butterfly Network, Inc
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Pulsenmore Ltd.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Leltek Inc.
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives